GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iNtRON Biotechnology Inc (XKRX:048530) » Definitions » Asset Turnover

iNtRON Biotechnology (XKRX:048530) Asset Turnover : 0.02 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is iNtRON Biotechnology Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. iNtRON Biotechnology's Revenue for the three months ended in Dec. 2024 was ₩1,522 Mil. iNtRON Biotechnology's Total Assets for the quarter that ended in Dec. 2024 was ₩88,671 Mil. Therefore, iNtRON Biotechnology's Asset Turnover for the quarter that ended in Dec. 2024 was 0.02.

Asset Turnover is linked to ROE % through Du Pont Formula. iNtRON Biotechnology's annualized ROE % for the quarter that ended in Dec. 2024 was -6.83%. It is also linked to ROA % through Du Pont Formula. iNtRON Biotechnology's annualized ROA % for the quarter that ended in Dec. 2024 was -6.67%.


iNtRON Biotechnology Asset Turnover Historical Data

The historical data trend for iNtRON Biotechnology's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iNtRON Biotechnology Asset Turnover Chart

iNtRON Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.23 0.10 0.08 0.07

iNtRON Biotechnology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.02 0.02 0.01 0.02

Competitive Comparison of iNtRON Biotechnology's Asset Turnover

For the Biotechnology subindustry, iNtRON Biotechnology's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iNtRON Biotechnology's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iNtRON Biotechnology's Asset Turnover distribution charts can be found below:

* The bar in red indicates where iNtRON Biotechnology's Asset Turnover falls into.


;
;

iNtRON Biotechnology Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

iNtRON Biotechnology's Asset Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=6417.829/( (98614.591+86374.616)/ 2 )
=6417.829/92494.6035
=0.07

iNtRON Biotechnology's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=1521.54/( (90966.449+86374.616)/ 2 )
=1521.54/88670.5325
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


iNtRON Biotechnology  (XKRX:048530) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

iNtRON Biotechnology's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-5912.96/86571.0635
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5912.96 / 6086.16)*(6086.16 / 88670.5325)*(88670.5325/ 86571.0635)
=Net Margin %*Asset Turnover*Equity Multiplier
=-97.15 %*0.0686*1.0243
=ROA %*Equity Multiplier
=-6.67 %*1.0243
=-6.83 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

iNtRON Biotechnology's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=-5912.96/88670.5325
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-5912.96 / 6086.16)*(6086.16 / 88670.5325)
=Net Margin %*Asset Turnover
=-97.15 %*0.0686
=-6.67 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


iNtRON Biotechnology Asset Turnover Related Terms

Thank you for viewing the detailed overview of iNtRON Biotechnology's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


iNtRON Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
137, Sagimakgol-ro, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
iNtRON Biotechnology Inc is a Korea-based company principally engaged in the biotechnology industry. It develops, manufactures, and commercializes drugs for the treatment of infectious diseases. It is contributing to national health and national prevention through several (molecular) diagnostic products such as swine flu, VRE super bacteria, food poisoning, avian influenza and foot, and mouth disease. In addition, it is also engaged in the operation of a veterinary antibiotic alternative business and new biopharmaceuticals development business.

iNtRON Biotechnology Headlines

No Headlines